Abiopharma

New Form 4 - CORE MOLDING TECHNOLOGIES INC Filed: 2025-06-20 AccNo: 0001026655-25-000061 Size: 7 KB

Halozyme - Halozyme Announces argenx Received European Commission Approval for VYVGART® Subcutaneous Injection withENHANZE® for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy

New Form SCHEDULE 13G - Inventiva S.A. Filed: 2025-06-20 AccNo: 0001172661-25-002447 Size: 14 KB

Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

SeaStar Medical - SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2025

FDA approve LENACAPAVIR

FDA approve TAFASITAMAB-CXIX

New Form 11-K - LINDE PLC Filed: 2025-06-20 AccNo: 0001628280-25-032289 Size: 230 KB

New Form 11-K - LINDE PLC Filed: 2025-06-20 AccNo: 0001628280-25-032286 Size: 179 KB

New Form 25-NSE - Kronos Bio, Inc. Filed: 2025-06-20 AccNo: 0001354457-25-000547 Size: 2 KB